Noa Ben-Baruch

5.3k total citations
38 papers, 1.3k citations indexed

About

Noa Ben-Baruch is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Noa Ben-Baruch has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Noa Ben-Baruch's work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Treatment and Pharmacology (7 papers). Noa Ben-Baruch is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Treatment and Pharmacology (7 papers). Noa Ben-Baruch collaborates with scholars based in Israel, United States and Belgium. Noa Ben-Baruch's co-authors include Yosef Yarden, Lior Soussan‐Gutman, Shulamith Rizel, Devarajan Karunagaran, Ido Wolf, Adva Yeheskel, Vincent A. Miller, Myles Brown, Keren Merenbakh-Lamin and Rinath Jeselsohn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Noa Ben-Baruch

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noa Ben-Baruch Israel	16	757	524	384	246	237	38	1.3k
Keltouma Driouch France	24	687 0.9×	1.3k 2.4×	425 1.1×	335 1.4×	120 0.5×	41	1.8k
Maria Sundvall Finland	20	949 1.3×	1.2k 2.2×	289 0.8×	149 0.6×	364 1.5×	33	1.8k
Hong-Mei Rong United States	5	852 1.1×	536 1.0×	285 0.7×	159 0.6×	525 2.2×	8	1.2k
Hakim Bouterfa Germany	23	1.0k 1.4×	573 1.1×	228 0.6×	136 0.6×	491 2.1×	40	2.4k
B. J. Kerns United States	16	1.2k 1.5×	880 1.7×	391 1.0×	233 0.9×	383 1.6×	25	2.2k
Todd R. Palmby United States	18	541 0.7×	927 1.8×	179 0.5×	96 0.4×	173 0.7×	19	1.6k
Franck Assayag France	17	668 0.9×	549 1.0×	388 1.0×	108 0.4×	127 0.5×	35	1.3k
Maria Niewolna United States	18	1.2k 1.6×	1.0k 1.9×	304 0.8×	105 0.4×	290 1.2×	23	2.0k
Frank Feleppa Australia	8	963 1.3×	816 1.6×	513 1.3×	238 1.0×	99 0.4×	9	1.5k
Jalila Adnane United States	18	939 1.2×	1.4k 2.7×	394 1.0×	233 0.9×	80 0.3×	23	2.1k

Countries citing papers authored by Noa Ben-Baruch

Since Specialization

Citations

This map shows the geographic impact of Noa Ben-Baruch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Ben-Baruch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Ben-Baruch more than expected).

Fields of papers citing papers by Noa Ben-Baruch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Ben-Baruch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Ben-Baruch. The network helps show where Noa Ben-Baruch may publish in the future.

Co-authorship network of co-authors of Noa Ben-Baruch

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Ben-Baruch. A scholar is included among the top collaborators of Noa Ben-Baruch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Ben-Baruch. Noa Ben-Baruch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zippel, Douglas, et al.. (2020). Advanced Breast Cancer at Diagnosis: Over One Third Adherent to Screening Recommendations. Women s Health Reports. 1(1). 301–307.

Denys, Hannelore, Marc Martens, Randal D’hondt, et al.. (2020). Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer. Breast Cancer Research and Treatment. 181(1). 97–105. 26 indexed citations

Stemmer, Salomon M., Mariana Steiner, Shulamith Rizel, et al.. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. npj Breast Cancer. 5(1). 41–41. 23 indexed citations

Stemmer, Salomon M., Shulamith Rizel, David Geffen, et al.. (2017). Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry. npj Breast Cancer. 3(1). 32–32. 68 indexed citations

Stemmer, Salomon M., Shulamit Rizel, Tamar Peretz, et al.. (2016). First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) result. Annals of Oncology. 27. vi44–vi44. 3 indexed citations

Ben-Baruch, Noa, Ron Bose, Shyam M. Kavuri, X. Cynthia, & Matthew J. Ellis. (2015). HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor. Journal of the National Comprehensive Cancer Network. 13(9). 1061–1064. 57 indexed citations

Stemmer, Salomon M., Shmuel Klang, Noa Ben-Baruch, et al.. (2013). The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast Cancer Research and Treatment. 140(1). 83–92. 34 indexed citations

Paluch–Shimon, Shani, Noa Ben-Baruch, Ido Wolf, et al.. (2009). Hormone Receptor Expression Is Associated With a Unique Pattern of Metastatic Spread and Increased Survival Among HER2-Overexpressing Breast Cancer Patients. American Journal of Clinical Oncology. 32(5). 504–508. 10 indexed citations

Avigad, Smadar, Dan Peleg, Noa Ben-Baruch, et al.. (2004). Prenatal Diagnosis in Li-Fraumeni Syndrome. Journal of Pediatric Hematology/Oncology. 26(9). 541–545. 6 indexed citations

10.

Idelevich, Efraim, M Mozes, Noa Ben-Baruch, et al.. (2003). Oncogenes in Male Breast Cancer. American Journal of Clinical Oncology. 26(3). 259–261. 6 indexed citations

11.

Ben-Baruch, Noa & Yosef Yarden. (1994). Neu Differentiation Factors: A Family of Alternatively Spliced Neuronal and Mesenchymal Factors. Experimental Biology and Medicine. 206(3). 221–227. 56 indexed citations

12.

Wen, Duanzhi, Sidney V. Suggs, Devarajan Karunagaran, et al.. (1994). Structural and Functional Aspects of the Multiplicity of Neu Differentiation Factors. Molecular and Cellular Biology. 14(3). 1909–1919. 202 indexed citations

13.

Bacus, S S, Andrei V. Gudkov, C R Zelnick, et al.. (1993). Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.. PubMed. 53(21). 5251–61. 92 indexed citations

14.

Brufman, G, Nissim Haim, Noa Ben-Baruch, & Aarón Sulkes. (1993). Second-Line Chemotherapy with Mitoxantrone as a Single Agent in Metastatic Breast Cancer. Journal of Chemotherapy. 5(1). 43–46. 11 indexed citations

15.

Pierce, Lori J., Marc E. Lippman, Noa Ben-Baruch, et al.. (1992). The effect of systemic therapy on local-regional control in locally advanced breast cancer. International Journal of Radiation Oncology*Biology*Physics. 23(5). 949–960. 65 indexed citations

16.

Surbone, Antonella, Harry Ford, James A. Kelley, et al.. (1990). Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).. PubMed. 50(4). 1220–5. 15 indexed citations

17.

Zajac‐Kaye, Maria, Bin Yu, & Noa Ben-Baruch. (1990). Downstream Regulatory Elements in the c-myc Gene. Current topics in microbiology and immunology. 166. 279–284. 1 indexed citations

18.

Mordel, Nathan, et al.. (1989). Malignant melanoma of the uterine cervix: Case report and review of the literature. Gynecologic Oncology. 32(3). 375–380. 35 indexed citations

19.

Gabizón, Alberto, Tamar Peretz, Aarón Sulkes, et al.. (1989). Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. European Journal of Cancer and Clinical Oncology. 25(12). 1795–1803. 105 indexed citations

20.

Mordel, Nathan, et al.. (1988). Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review.. PubMed. 33(7). 649–55. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact